col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


200 Ergebisse       Seite 1

 [1] 
Wiley: Journal of Thrombosis and Haemostasis
  Original Artikel Datum Titel Autoren   Max. 6 Autoren
1 [GO] 2026―Jun―18 Intermediate-dose anticoagulation in COVID-19: closing the loop on a long-settled question Behnood Bikdeli, Alex C. Spyropoulos
2 [GO] 2026―Mai―09 Shear-cytokine crosstalk is a determinant of SARS-CoV-2 induced endothelial pathophysiology and thrombosis in human vessel-chips Sreelakshmy Suresh, Rebecca John, John P. Cooke, John H. Connor, Abhishek Jain
3 [GO] 2026―Mrz―26 Intermediate Dose Heparin Thromboprophylaxis among Critically Ill Patients with COVID-19: A Randomised Clinical Trial Victoria Manax, Jason Connor, Julian Bion, Simon Gates, John Reynolds, Tom van der Poll, Derek Angus, Djillali Annane, Yaseen Arabi, Diptesh Aryal, Abigail Beane, Scott Berry, Marc Bonten, Charlotte Bradbury, Frank Brunkhorst, Aidan Burrell, Meredith Buxton, Maurizio Cecconi, Allen Cheng, Matthew Cove, Lennie Derde, Lise Estcourt, Anthony Gordon, Cameron Green, Rashan Haniffa, Leanne Hays, Alisa Higgins, Thomas Hills, David Huang, Nao Ichihara, Devachandran Jayakumar, Francois Lamontagne, Janis Best-Lane, Patrick Lawler, John Marshall, Colin McArthur, Daniel McAuley, Shay McGuinness, Zoe McQuilten, Bryan McVerry, Susan Morpeth, Paul Mouncey, Srinivas Murthy, Alistair Nichol, Rachael Parke, Jane Parker, Svenja Peters, Luis Felipe Reyes, Kathryn Rowan, Hiroki Saito, Marlene Santos, Christopher Seymour, Manu Shankar-Hari, Vanessa Singh, Alexis Turgeon, Anne Turner, Frank van de Veerdonk, Steve Webb, Ryan Zarychanski ; Yaseen Arabi, Aidan Burrell, Lewis Campbell, Allen Cheng, Lennie Derde, Andrew Forbes, David Gattas, Cameron Green, Stephane Heritier, Thomas Hills, Peter Kruger, Colin McArthur, Shay McGuinness, Zoe McQuilten, Susan Morpeth, Alistair Nichol, Rachael Parke, Jane Parker, Sandra Peake, Jeffrey Presneill, Claire Reynolds, Manoj Saxena, Ian Seppelt, Vanessa Singh, Tony Trapani, Anne Turner, Bec Ward-Smith, Steve Webb (, Paul Young, Hannah Tolley, Lane Carrandi, Brian Cuthbertson, Rob Fowler, Francois Lamontagne, John Marshall (, Venika Manoharan, Srinivas Murthy, Marlene Santos, Alexis Turgeon, Ryan Zarychanski, Diptesh Aryal, Abigail Beane, Arjen M. Dondrop, Cameron Green, Rashan Haniffa, Mohd Shahnaz Bin Hasan, Madiha Hashmi, Devachandran Jayakumar, Ismail Kalla, John Marshall, Colin McArthur, Srinivas Murthy, Lyle Murray, Sumayyah Rashan, Luis Felipe Reyes, Vanessa Singh, Steve Webb, Derek Angus, Djillali Annane, Scott Berry, Janis Best-Lane, Marc Bonten, Frank Brunkhorst, Maurizio Cecconi, Julian de la Torre Cisneros, Lennie Derde, Stephan Ehrmann, Anthony Gordon, Cameron Green, Colin McArthur, Paul Mouncey, Alistair Nichol, Svenja Peters, Mathias Pletz, Kathryn Rowan, Eveline Verheijen, Steve Webb, Sebastian Weis, Brian Alexander, Derek Angus (, Kim Basile, Meredith Buxton, Sarah Englert, Timothy Girard, Christopher Horvat, David Huang, India Loar, Florian Mayr, Bryan McVerry, Tracey Roberts, Christopher Seymour, Ali Smith, Yohei Doi, Shigeki Fujitani, Hitoshi Honda, Nao Ichihara, Kazuaki Jindai, Kazuhiro Kamata, Hideaki Kato, Hiroyuki Kunishima, Kenichi Nakazono, Hiroki Saito, Ayumi Shintani, Yoshiaki Yamagishi, Chizuru Yamashita, Matthew Cove, Cameron Green, Abdul Jabber Bin Ismail, Faheem Ahmed Khan, Ryanna Koh, Bastian Lubis, Jenny Low, Monvasi Pachinburavan, Jason Phua, Nattachai Srisawat, Paul Tambyah, Steve Webb, Sewa Duu Wen, Tsin Wen Yeo, Barnaby Young, Charlotte A. Bradbury, Bryan J. McVerry, Patrick R. Lawler, Derek C. Angus, Djillali Annane, Yaseen M. Arabi, Diptesh Aryal, Carly Au, Abigail Beane, Scott M. Berry, Lindsay R. Berry, Janis Best-Lane, Shailesh Bihari, Marc Bonten, Frank Brunkhorst, Aidan Burrell, Meredith Buxton, Marc Carrier, Maurizio Cecconi, Allen C. Cheng, Matthew Cove, Lennie P.G. Derde, Michelle A. Detry, Lise J. Estcourt, Dean A. Fergusson, Mark Fitzgerald, Rob A. Fowler, Ewan C. Goligher, Cameron Green, Rashan Haniffa, David A. Harrison, Leanne M.C. Hays, Alisa M. Higgins, Thomas Hills, Christopher M. Horvat, David T. Huang, Beverley J. Hunt, Nao Ichihara, Devachandran Jayakumar, Stephanie Keattch, Anand Kumar, Michael A. Laffan, Francois Lamontagne, Christine M. Leeper, Roger J. Lewis, Elizabeth Lorenzi, Sylvain A. Lother, John C. Marshall, Colin J. McArthur, Daniel F. McAuley, Anna McGlothlin, Shay P. McGuinness, Zoe K. McQuilten, Saskia Middeldorp, Susan Morpeth, Paul R. Mouncey, Srinivas Murthy, Matthew D. Neal, Alistair D. Nichol, Rachael L. Parke, Jane C. Parker, Svenja Peters, Lusi Felipe Reyes, Kathryn Rowan, Hiroki Saito, Marlene Santos, Christina T. Saunders, Roger E.G. Schutgens, Christopher W. Seymour, Manu Shankar Hari, Vanessa Singh, Simon J. Stanworth, Alexis F. Turgeon, Anne M. Turner, Frank L. van de Veerdonk, Anthony C. Gordon, Steve A. Webb, Ryan Zarychanski
4 [GO] 2026―Jan―14 Components of metabolic syndrome affect COVID-19 outcomes via platelet aggregation Qian Yu, Masako Nishikawa, Yuqi Zhou, Hongqian Zhang, Huidong Wang, Junyu Chen, Takeya Tsutsumi, Makoto Kurano, Yutaka Yatomi, Shenghong Ju, Keisuke Goda
5 [GO] 2025―Nov―08 TAFI downregulation prevents fibrinolysis shutdown and improves disease severity in SARS-CoV-2-infected K18-hACE2 mice Roberto Aiolfi, Antonella Zampolli, Hiroshi Deguchi, Jose A. Fernández, Angel Gandarilla, Juan Carlos de la Torre, Laurent O. Mosnier
6 [GO] 2025―Nov―03 In-situ pulmonary thrombosis and pulmonary embolus are distinct thrombotic phenotypes in critically ill patients with COVID-19 ARDS Daniël G. Aynekulu Mersha, Boaz Lopuhaä, Hester A. Gietema, Jim Smit, Anne E. Wind, Anne-Marije Hulshof, Katrijn Daenen, Jessica Khyali, Bas C.T. van Bussel, Matthijs F.M. van Oosterhout, Hazra S. Moeniralam, Eva K. Kempers, Marieke J.H.A. Kruip, Frederikus A. Klok, Virgil A.S.H. Dalm, Henrik Endeman, Eric C.M. Van Gorp, Willem A. Dik, Jan H. von der Thüsen, Nicole P. Juffermans
7 [GO] 2025―Okt―18 Acquired Haemophilia A Following SARS-CoV-2 Infection and Vaccination: Clinical Summary and Insights Alyssa L. Carlson, Jeremy Althouse, Naveed Ahmed, Matthew A. Nazari, Hussam Alkaissi
8 [GO] 2025―Apr―25 Venous Thromboembolism after Hospitalization for COVID-19: Venous Thrombosis Virtual Surveillance in COVID (VVIRTUOSO) Study Deborah M. Siegal, Marie-Pier Arsenault, Jameel Abdulrehman, Andrea Cervi, Andrew Cheung, Adam Cuker, Aurelien Delluc, Maral Koolian, Grégoire Le Gal, Ranjeeta Mallick, Alexa Moschella, Margaret Ostrowski, Chantal Rockwell, Prism Schneider, Tobias Tritschler, Carol West, Tzu-Fei Wang, Ryan Zarychanski, Marc Carrier
9 [GO] 2025―Apr―08 Angiostatin - A Novel SARS-CoV-2 Inhibitor and Biomarker Underlying COVID-19 Pathophysiology Aleksandra Franczak, Michael Joyce, Joaquin Lopez-Orozco, Holly A. Saffran, Max Saito, Amir Asgari, Subha Kalyaanamoorthy, Khaled Barakat, Tom C. Hobman, D. Lorne Tyrrell, Paul Jurasz
10 [GO] 2025―Apr―08 Detection of SARS-CoV-2 in bone marrow megakaryocytes and elevated emperipolesis in COVID-19 patients with thrombocytopenia Cédric Garcia, Fanny Vardon-Bounes, Baptiste Compagnon, Céline Guilbeau-Frugier, Sophie Voisin, Jean-Baptiste Rieu, Véronique De Mas, Bernard Payrastre, Agnès Ribes
11 [GO] 2025―Jan―10 DESCRIPTION OF THE CLINICAL AND RADIOLOGICAL CHARACTERISTICS OF PULMONARY EMBOLISM IN COVID-19 VERSUS NON COVID-19 PATIENTS: A MULTICENTRIC CROSS-SECTIONAL STUDY OVER A 24-MONTH PERSPECTIVE Paola Sterpone, Marco Paolo Donadini, Irene Abatangelo, Laura Tofanelli, Asim Raza, Filippo Piacentino, Francesco Maria Vitale, Francesco Ricapito, Massimo Venturini, Walter Ageno, Francesco Pavesi, Eleonora Antonucci, Maurizio Cariati, Gian Marco Podda, Simone Birocchi
12 [GO] 2024―Nov―28 “Four years into the pandemic, managing COVID-19 patients with acute coagulopathy: what have we learned?” Comment from Wada et al Hideo Wada, Takeshi Matsumoto, Katsuya Shiraki
13 [GO] 2024―Nov―28 Reply to the comments on “Four years into the pandemic, managing COVID-19 patients with acute coagulopathy: what have we learned?” from Wada et al. Toshiaki Iba, Jerrold H. Levy
14 [GO] 2024―Okt―11 Corrigendum to ‘COVID-19 outcomes in persons with hemophilia: results from a US-based national COVID-19 surveillance registry’ [Journal of Thrombosis and Haemostasis Volume 22, Issue 1, January 2024, Pages 61-75] Anjali Sharathkumar, Linder Wendt, Chris Ortman, Ragha Srinivasan, Christopher G. Chute, Elizabeth Chrischilles, Clifford M. Takemoto
15 [GO] 2024―Aug―23 “2023 ISTH update of the 2022 ISTH guidelines for antithrombotic treatment in COVID-19”: comment from Flumignan et al. Ronald Luiz Gomes Flumignan, Luis Carlos Uta Nakano, Jorge Eduardo de Amorim, Álvaro Nagib Atallah
16 [GO] 2024―Aug―23 “2023 ISTH update of the 2022 ISTH guidelines for antithrombotic treatment in COVID-19”: reply Sam Schulman, Helaine E. Resnick
17 [GO] 2024―Aug―14 Universal Clinical Decision Support Tool for Thromboprophylaxis in Hospitalized COVID-19 Patients: Post-Hoc Analysis of the IMPROVE-DD Cluster Randomized Trial Mark Goldin, Nikolaos Tsaftaridis, Ioannis Koulas, Jeffrey Solomon, Michael Qiu, Tungming Leung, Kolton Smith, Kanta Ochani, Thomas McGinn, Alex C. Spyropoulos
18 [GO] 2024―Jun―28 Microbiota-driven coagulation activation during SARS-CoV-2 infection Swati Sharma, Silvio Antoniak
19 [GO] 2024―Mai―28 Extracellular histones: a unifying mechanism driving platelet-dependent extracellular vesicle release and thrombus formation in COVID-19 Alicia S. Eustes, Azaj Ahmed, Jagadish Swamy, Gokul Patil, Melissa Jensen, Katina M. Wilson, Shibani Kudchadkar, Abdul Wahab, Usha Perepu, Francis J. Miller, Steven R. Lentz, Sanjana Dayal
20 [GO] 2024―Mai―17 ECMO aggravates platelet GPV shedding and δ-granule deficiency in COVID-19-associated acute respiratory distress syndrome Johannes Herrmann, Lukas J. Weiss, Bastian Just, Kristina Mott, Maria Drayss, Judith Kleiss, Jonathan Riesner, Quirin Notz, Daniel Röder, Rainer Leyh, Sarah Beck, Dirk Weismann, Bernhard Nieswandt, Christopher Lotz, Patrick Meybohm, Harald Schulze
21 [GO] 2024―Mrz―18 2023 ISTH update of the 2022 ISTH guidelines for antithrombotic treatment in COVID-19 Sam Schulman, Donald M. Arnold, Charlotte A. Bradbury, Lisa Broxmeyer, Jean Marie Connors, Anna Falanga, Toshiaki Iba, Scott Kaatz, Jerrold H. Levy, Saskia Middeldorp, Tracy Minichiello, Ishac Nazy, Eduardo Ramacciotti, Helaine E. Resnick, Charles Marc Samama, Michelle Sholzberg, Jecko Thachil, Ryan Zarychanski, Alex C. Spyropoulos
22 [GO] 2024―Mrz―05 Role of Microbiota-Derived Corisin in Coagulation Activation during SARS-CoV-2 Infection Tatsuki Tsuruga, Hajime Fujimoto, Taro Yasuma, Corina N. D’Alessandro-Gabazza, Masaaki Toda, Toshiyuki Ito, Atsushi Tomaru, Haruko Saiki, Tomohito Okano, Manal A.B. Alhawsawi, Atsuro Takeshita, Kota Nishihama, Reoto Takei, Yasuhiro Kondoh, Isaac Cann, Esteban C. Gabazza, Tetsu Kobayashi.
23 [GO] 2024―Feb―29 Four years into the pandemic, managing COVID-19 patients with acute coagulopathy: what have we learned? Toshiaki Iba, Jerrold H. Levy, Cheryl L. Maier, Jean M. Connors, Marcel Levi
24 [GO] 2024―Feb―02 Uncertainties about the roles of anticoagulation and microclots in post-acute sequelae of SARS-CoV-2 infection-response to the letter by Kell et al. Jean M. Connors, Robert A.S. Ariëns
25 [GO] 2024―Feb―02 Uncertainties about the roles of anticoagulation and microclots in postacute sequelae of SARS-CoV-2 infection: comment from Kell et al. Douglas B. Kell, M. Asad Khan, Gert Jacobus Laubscher, Etheresia Pretorius
26 [GO] 2023―Okt―04 COVID-19 promotes endothelial dysfunction and thrombogenicity: Role of pro-inflammatory cytokines/SGLT2 pro-oxidant pathway Ali Mroueh, Walaa Fakih, Adrien Carmona, Antonin Trimaille, Kensuke Matsushita, Benjamin Marchandot, Abdul Wahid Qureshi, Dal-Seong Gong, Cyril Auger, Laurent Sattler, Antje Reydel, Sébastien Hess, Walid Oulehri, Olivier Vollmer, Jean-Marc Lessinger, Nicolas Meyer, Michael-Paul Pieper, Laurence Jesel, Magnus Bäck, Valérie Schini-Kerth, Olivier Morel
27 [GO] 2023―Sep―23 NETs induce persistent lung tissue damage via thromboinflammation without altering virus resolution in a mouse coronavirus model Manuel Salzmann, Patrizia Gibler, Patrick Haider, Mira Brekalo, Roberto Plasenzotti, Thomas Filip, Rebecca Nistelberger, Boris Hartmann, Johann Wojta, Christian Hengstenberg, Bruno K. Podesser, Julia B. Kral-Pointner, Philipp J. Hohensinner
28 [GO] 2023―Aug―07 Characterization of all small RNAs in and comparisons across cultured megakaryocytes and platelets of healthy individuals and COVID-19 patients Stepan Nersisyan, Emilie Montenont, Phillipe Loher, Elizabeth A. Middleton, Robert Campbell, Paul Bray, Isidore Rigoutsos
29 [GO] 2023―Jul―25 Uncertainties about the Roles of Anticoagulation and Microclots in Post-acute Sequelae of SARS-CoV-2 Infection Jean M. Connors, Robert A.S. Ariëns
30 [GO] 2023―Jul―17 A commentary on “Thromboinflammation in long COVID - the elusive key to post-infection sequelae?” Toshiaki Iba, Jerrold H. Levy
31 [GO] 2023―Jul―08 Thrombosis, major bleeding, and survival in COVID-19 supported by VV- ECMO in the first vs second wave- multicentre observational study in the UK. Deepa J. Arachchillage, Anna Weatherill, Indika Rajakaruna, Mihaela Gaspar, Zain Odho, Graziella Isgro, Lenka Cagova, Lucy Fleming, Stephane Ledot, Mike Laffan, Richard Szydlo, Rachel Jooste, Ian Scott, Alain Vuylsteke, Hakeem Yusuff
32 [GO] 2023―Jun―01 Thrombotic Complications in Children with COVID-19 and MIS-C Riten Kumar, Michael J. Rivkin, Leslie Raffini
33 [GO] 2023―Mai―23 A RANDOMISED CONTROLLED TRIAL TO INVESTIGATE THE USE OF ACUTE CORONARY SYNDROME THERAPY IN PATIENTS HOSPITALISED WITH COVID-19: THE C19-ACS TRIAL Prapa Kanagaratnam, Darrel P. Francis, Daniel Chamie, Clare Coyle, Alena Marynina, George Katritsis, Patricia Paiva, Matyas Szigeti, Graham Cole, David de Andrade Nunes, James Howard, Rodrigo Esper, Masood Khan, Ranjit More, Guilherme Barreto, Rafael Meneguz-Moreno, Ahran Arnold, Alexandra Nowbar, Amit Kaura, Myril Mariveles, Katherine March, Jaymin Shah, Sukhjinder Nijjer, Gregory YH. Lip, Nicholas Mills, A John Camm, Graham S. Cooke, Simon J. Corbett, Martin J. Llewelyn, Waleed Ghanima, Mark Toshner, Nicholas Peters, Ricardo Petraco, Rasha Al-Lamee, Ana Sousa Marcelino Boshoff, Margarita Durkina, Iqbal Malik, Neil Ruparelia, Victoria Cornelius, Matthew Shun-Shin
34 [GO] 2023―Mai―13 COVID-19 outcomes in persons with hemophilia: results from a US-based national COVID-19 surveillance registry Anjali Sharathkumar, Linder Wendt, Chris Ortman, Ragha Srinivasan, Christopher Chute, Elizabeth Chrischilles, Clifford Takemoto
35 [GO] 2023―Mai―11 Thrombo-inflammation in Long COVID - the elusive key to post-infection sequelae? Leo Nicolai, Rainer Kaiser, Konstantin Stark
36 [GO] 2023―Apr―11 NETosis induction reflects COVID-19 severity and Long COVID: insights from a two-center patient cohort study in Israel Nitzan Krinsky, Sofia Sizikov, Sivan Nissim, Adi Dror, Anna Sas, Hodaya Prinz, Ester Pri-Or, Shay Perek, Ayelet Raz-Pasteur, Izabella Lejbkowicz, Sivan Ida Cohen-Matsliah, Ronit Almog, Nikanor Chen, Ramzi Kurd, Amir Jarjou'i, Ariel Rokach, Eli Ben-Chetrit, Avi Schroeder, Aleah F. Caulin, Christian Con Yost, Joshua D. Schiffman, Mor Goldfeder, Kimberly Martinod
37 [GO] 2023―Mrz―12 Distinct platelet crosstalk with adaptive and innate immune cells after adenoviral and mRNA vaccination against SARS-CoV-2. Ludovica Lombardi, Francesca Maiorca, Ramona Marrapodi, Annamaria Sabetta, Noemi Scafa, Davide Pallucci, Marzia Miglionico, Giulio F. Romiti, Bernadette Corica, Silvia Piconese, Antonella Polimeni, Fabio Pulcinelli, Roberto Cangemi, Marcella Visentini, Stefania Basili, Lucia Stefanini
38 [GO] 2023―Feb―28 “Thromboinflammation in COVID-19: can α2-macroglobulin help to control the fire?”: Comment from Seitz et al. Rainer Seitz, Lutz Gürtler, Wolfgang Schramm
39 [GO] 2023―Jan―28 Alterations in platelet proteome signature and impaired platelet integrin αIIbβ3 activation in patients with COVID-19 Lucy J. Goudswaard, Christopher M. Williams, Jawad Khalil, Kate L. Burley, Fergus Hamilton, David Arnold, Alice Milne, Phil A. Lewis, Kate J. Heesom, Stuart J. Mundell, Andrew D. Davidson, Alastair W. Poole, Ingeborg Hers
40 [GO] 2023―Jan―25 Peripheral blood mononuclear cell tissue factor (F3 gene) transcript levels and circulating extracellular vesicles are elevated in severe COVID-19 disease Thomas J. Girard, Lilian Antunes Heck, Nan Zhang, Junedh M. Amrute, Renumathi Subramanian, Irem Eldem, Kenneth E. Remy, Monty Mazer, Emma C. Erlich, Carlos Cruchaga, Ashley L. Steed, Gwendalyn J. Randolph, Jorge Di Paola
41 [GO] 2022―Okt―22 ISTH guidelines for antithrombotic treatment in COVID-19”: Reply Sam Schulman, Michelle Sholzberg, Alex C. Spyropoulos, Ryan Zarychanski
42 [GO] 2022―Aug―25 Most impactful COVID-19 articles in the field of thrombosis and hemostasis literature Eyal Klang, Gili Kenet, Sarina Levy-Mendelovich
43 [GO] 2022―Aug―15 “Unconventional CD147 -dependent platelet activation elicited by SARS-CoV -2 in COVID -19”: Comment from Wada et al Hideo Wada, Katsuya Shiraki, Katsue Suzuki-Inoue
44 [GO] 2022―Aug―15 “Unconventional CD147 -dependent platelet activation elicited by SARS-CoV -2 in COVID -19”: Reply Norma Maugeri, Angelo A. Manfredi
45 [GO] 2022―Jul―25 Sustained VWF-ADAMTS13 axis imbalance and endotheliopathy in Long COVID syndrome is related to immune dysfunction Helen Fogarty, Soracha E. Ward, Liam Townsend, Ellie Karampini, Stephanie Elliott, Niall Conlon, Jean Dunne, Rachel Kiersey, Aifric Naughton, Mary Gardiner, Mary Byrne, Colm Bergin, Jamie M. O’Sullivan, Ignacio Martin-Loeches, Parthiban Nadarajan, Ciaran Bannan, Patrick W. Mallon, Gerard F. Curley, Roger J. S. Preston, Aisling M. Rehill, Ross I. Baker, Cliona Ni Cheallaigh, James S. O’Donnell
46 [GO] 2022―Jun―27 Commentary on “Risk of venous thromboembolism after COVID-19 vaccination” Corinne Frere, Joe-Elie Salem
47 [GO] 2022―Mai―21 The thrombosis and haemostasis community network come face-to-face in a new (almost) post pandemic world Beverley Hunt, Robert A. S. Ariëns
48 [GO] 2022―Mai―05 Refractory immune TTP following Pfizer-BioNTech COVID-19 vaccine successfully salvaged with caplacizumab Eva Laverdure, Catherine Sperlich, Susan Fox
49 [GO] 2022―Apr―10 Risk of Venous Thromboembolism after COVID-19 Vaccination Damon E. Houghton, Waldemar Wysokinski, Ana I. Casanegra, Leslie J. Padrnos, Surbhi Shah, Ewa Wysokinska, Rajiv Pruthi, Aneel Ashrani, Meera Sridharan, Lisa Baumann-Kreuziger, Robert McBane, Anand Padmanabhan
50 [GO] 2022―Mrz―22 Altered fibrin network structure and fibrinolysis in intensive care unit patients with COVID-19, not entirely explaining the increased risk of thrombosis Judith J. de Vries, Chantal Visser, Lotte Geers, Johan A. Slotman, Nadine D. van Kleef, Coen Maas, Hannelore I. Bax, Jelle R. Miedema, Eric C.M. van Gorp, Marco Goeijenbier, Johannes P.C. van den Akker, Henrik Endeman, Dingeman C. Rijken, Marieke J.H.A. Kruip, Moniek P.M. de Maat
51 [GO] 2022―Mrz―22 Bleeding risk of intramuscular injection of COVID-19 vaccines in adult patients with therapeutic anticoagulation Nicolas Gendron, Lina Khider, Christine Le Beller, Benjamin Espinasse, Claire Auditeau, Wafa Amara, Germain Perrin, David Lebeaux, Anais Gaiffe, Sandrine Combret, Blandine Bertin, Agnès Lillo-Le Louet, Tristan Mirault, David M Smadja, Olivier Sanchez, Cécile Tromeur, Benjamin Planquette, Francis Couturaud
52 [GO] 2022―Mrz―21 Real world, single centre experience of SARS-CoV-2 vaccination in Immune Thrombocytopenia Philippa Woolley, Anish Tailor, Raakhee Shah, John-Paul Westwood, Marie Scully
53 [GO] 2022―Feb―27 Scientific method and the COVID pandemic David Lillicrap, James H. Morrissey
54 [GO] 2022―Feb―17 Shining a Light on Platelet Activation in COVID-19 Frederik Denorme, Abigail Ajanel, Robert A. Campbell
55 [GO] 2022―Feb―14 Platelet size as a mirror for the immune response after SARS-CoV-2 vaccination Thomas Thiele, Silas L. Schwarz, Stefan Handtke
56 [GO] 2022―Feb―12 Thrombosis pathways in COVID-19 versus influenza-associated ARDS: a targeted proteomics approach Emma Rademaker, Dennis J. Doorduijn, Nuray Kusadasi, Coen Maas, Julia Drylewicz, Albert Huisman, Imo E. Hoefer, Marc J. M. Bonten, Lennie P. G. Derde, Suzan H. M. Rooijakkers, Olaf L. Cremer
57 [GO] 2022―Feb―02 Investigating potential mechanisms underlying FVIII inhibition in acquired hemophilia A associated with mRNA COVID-19 vaccines Julia R. Hirsiger, Maria Martinez, Dimitrios A. Tsakiris, Micol G. Cittone, Lukas Graf, Johannes Oldenburg, Behnaz Pezeshkpoor, Mike Recher, Jens Mueller, Bernhard Gerber, Christoph T. Berger
58 [GO] 2022―Feb―01 Non-severe COVID-19 is associated with endothelial damage and hypercoagulability despite pharmacological thromboprophylaxis Sarah Kelliher, Luisa Weiss, Sarah Cullivan, Ellen O’Rourke, Claire A. Murphy, Shane Toolan, Áine Lennon, Paulina B. Szklanna, Shane P. Comer, Hayley Macleod, Ana Le Chevillier, Sean Gaine, Kate M. A. O’Reilly, Brian McCullagh, John Stack, Patricia B. Maguire, Fionnuala Ní Áinle, Barry Kevane
59 [GO] 2022―Jan―15 Impact of COVID-19 on thrombus composition and response to thrombolysis: Insights from a monocentric cohort population of COVID-19 patients with acute ischemic stroke Jean-Philippe Desilles, Mialitiana Solo Nomenjanahary, Arturo Consoli, Véronique Ollivier, Dorothée Faille, Marie-Charlotte Bourrienne, Mylène Hamdani, Sébastien Dupont, Lucas Di Meglio, Simon Escalard, Benjamin Maier, Raphael Blanc, Michel Piotin, Bertrand Lapergue, Nadine Ajzenberg, Marc Vasse, Mikael Mazighi, Benoît Ho-Tin-Noé
60 [GO] 2022―Jan―15 Platelet and immune signature associated with a rapid response to the BNT162b2 mRNA Covid-19 Vaccine Davide Flego, Simone Cesaroni, Giulio F. Romiti, Bernadette Corica, Ramona Marrapodi, Noemi Scafa, Francesca Maiorca, Ludovica Lombardi, Davide Pallucci, Fabio Pulcinelli, Valeria Raparelli, Marcella Visentini, Roberto Cangemi, Silvia Piconese, Domenico Alvaro, Antonella Polimeni, Stefania Basili, Lucia Stefanini
61 [GO] 2021―Dez―31 The COVID-19 vaccine ChAdOx1-S is not contaminated with sulfated glycosaminoglycans Susanne Alban, Sandesh Neupane, Ulrich Girreser, Frank D. Sönnichsen, Andreas Greinacher
62 [GO] 2021―Nov―19 COVID-19 - Two years in David Lillicrap, James H. Morrissey
63 [GO] 2021―Nov―09 Antibody-mediated procoagulant platelet formation in COVID-19 is AKT dependent Lisann Pelzl, Anurag Singh, Jonas Funk, Andreas Witzemann, Irene Marini, Jan Zlamal, Karoline Weich, Wissam Abou-Khalel, Stefanie Hammer, Guenalp Uzun, Karina Althaus, Tamam Bakchoul
64 [GO] 2021―Nov―05 More on Persistent Endotheliopathy in the Pathogenesis of Long COVID Syndrome Helen Fogarty, Ellie Karampini, Andrew S. O’Donnell, Soracha E. Ward, Jamie M O’Sullivan, James S. O’Donnell
65 [GO] 2021―Nov―03 Persistent Endotheliopathy in the Pathogenesis of Long COVID Syndrome: COMMENT from von Meijenfeldt et al. Fien A. von Meijenfeldt, Sebastian Havervall, Jelle Adelmeijer, Charlotte Thalin, Ton Lisman
66 [GO] 2021―Okt―28 Unconventional CD147-dependent platelet activation elicited by SARS-CoV-2 in COVID-19 Norma Maugeri, Rebecca De Lorenzo, Nicola Clementi, Roberta Antonia Diotti, Elena Criscuolo, Cosmo Godino, Cristina Tresoldi, Chiara Bonini, Massimo Clementi, Nicasio Mancini, Fabio Ciceri, Patrizia Rovere-Querini, Angelo A Manfredi
67 [GO] 2021―Okt―21 Role of neutrophils, platelets and extracellular vesicles and their interactions in Covid-19-associated thrombopathy Antoine Caillon, Antonin Trimaille, Julie Favre, Laurence Jesel, Olivier Morel, Gilles Kauffenstein
68 [GO] 2021―Sep―19 Use of Novel Antithrombotic Agents for COVID-19: Systemic Summary of Ongoing Randomized Controlled Trials Azita H. Talasaz, Parham Sadeghipour, Maryam Aghakouchakzadeh, Hessam Kakavand, Hamid Ariannejad, Jean M. Connors, Beverley J. Hunt, Jeffrey S. Berger, Benjamin W. Van Tassell, Saskia Middeldorp, Gregory Piazza, Jeffrey I. Weitz, Mary Cushman, Gregory Y.H. Lip, Samuel Z. Goldhaber, Behnood Bikdeli
69 [GO] 2021―Sep―19 Pathology of lung-specific thrombosis and inflammation in COVID-19 Rafael R. Khismatullin, Anastasia A. Ponomareva, Chandrasekaran Nagaswami, Rozalina A. Ivaeva, Kathleen T. Montone, John W. Weisel, Rustem I. Litvinov
70 [GO] 2021―Sep―19 Platelets Contribute to Disease Severity in COVID-19 Tessa J. Barrett, Seda Bilaloglu, Macintosh Cornwell, Hannah M Burgess, Vitor W Virginio, Kamelia Drenkova, Homam Ibrahim, Eugene Yuriditsky, Yin Aphinyanaphongs, Mark Lifshitz, Feng Xia Liang, Julie Alejo, Grace Smith, Stefania Pittaluga, Amy V Rapkiewicz, Jun Wang, Camelia Iancu-Rubin, Ian Mohr, Kelly Ruggles, Kenneth A. Stapleford, Judith Hochman, Jeffrey S. Berger
71 [GO] 2021―Aug―29 Association of Pre-Hospital Antiplatelet Therapy with Survival in Patients Hospitalized with COVID-19: A Propensity Score-Matched Analysis Jonathan H. Chow, Ying Yin, David P. Yamane, Danielle Davison, Ryan Keneally, Katrina Hawkins, Gage Parr, Mustafa Al-Mashat, Jeffery S. Berger, Reamer L. Bushardt, Michael A. Mazzeffi, Stuart J. Nelson
72 [GO] 2021―Aug―26 Impact of the COVID-19 pandemic on education and clinical training Muntadhar Al Moosawi, Aaron Iding, Paul Armstrong, Thita Chiasakul, Robert Campbell, Caterina Casari, Claire McLintock, Muntadhar Al Moosawi, Paul Armstrong, Rose Brazilek, Robert Campbell, Caterina Casari, Thita Chiasakul, Sofija Dunjic Manevski, Renee Eslick, Aaron Iding, Shrey Kohli, Lauren Poole, Leslie Skeith
73 [GO] 2021―Aug―21 Tissue factor expression, extracellular vesicles and thrombosis after infection with the respiratory viruses influenza A virus and coronavirus Nigel Mackman, Steven P Grover, Silvio Antoniak
74 [GO] 2021―Aug―12 Education of healthcare professionals and the public about thrombosis and COVID-19 Beverley Hunt
75 [GO] 2021―Aug―10 Comparison of adverse drug reactions among four COVID-19 vaccines in Europe using the EudraVigilance database: thrombosis at unusual sites Maria Abbattista, Ida Martinelli, Flora Peyvandi
76 [GO] 2021―Aug―10 Persistent Endotheliopathy in the Pathogenesis of Long COVID Syndrome Helen Fogarty, Liam Townsend, Hannah Morrin, Azaz Ahmad, Claire Comerford, Ellie Karampini, Hanna Englert, Mary Byrne, Colm Bergin, Jamie M. O’Sullivan, Ignacio Martin-Loeches, Parthiban Nadarajan, Ciaran Bannan, Patrick W. Mallon, Gerard F. Curley, Roger J.S. Preston, Aisling M. Rehill, Dennis McGonagle, Cliona Ni Cheallaigh, Ross I. Baker, Thomas Renné, Soracha E. Ward, James S. O’ Donnell
77 [GO] 2021―Jul―31 Reply to the letter entitled “Suggested treatment of serious complications to Covid-19 vaccination with IdeS, a bacterial antibody-cleaving enzyme” Yves Gruel, Caroline Vayne, Jérôme Rollin, Claire Pouplard
78 [GO] 2021―Jul―27 Laboratory testing for post ChAdOx1 nCOV-19 vaccination VITT: A challenge. Comment on: Recommendations for the clinical and laboratory diagnosis of VITT against COVID-19: Communication from the ISTH SSC Subcommittee on Platelet Immunology Kobe Vercruysse, Katrien M. J. Devreese
79 [GO] 2021―Jul―17 Thrombocytopenia with acute ischemic stroke and bleeding in a patient newly vaccinated with an adenoviral vector-based COVID-19 vaccine: COMMENT: COMMENT from Gruel et al.: RESPONSE from Kahn et al. Fredrik Kahn, Oongh Shannon, Lars Björck
80 [GO] 2021―Jul―14 The CoVID-TE Risk Assessment Model for Venous Thromboembolism in Hospitalized Patients with Cancer and COVID-19 Ang Li, Nicole M. Kuderer, Chih-Yuan Hsu, Yu Shyr, Jeremy L. Warner, Dimpy P. Shah, Vaibhav Kumar, Surbhi Shah, Amit A. Kulkarni, Julie Fu, Shuchi Gulati, Rebecca L. Zon, Monica Li, Aakash Desai, Pamela C. Egan, Ziad Bakouny, Devendra KC, Clara Hwang, Imo J. Akpan, Rana R. McKay, Jennifer Girard, Andrew L. Schmidt, Balazs Halmos, Michael A. Thompson, Jaymin M. Patel, Nathan A. Pennell, Solange Peters, Amro Elshoury, Gilbero de Lima Lopes, Daniel G. Stover, Petros Grivas, Brian I. Rini, Corrie A. Painter, Sanjay Mishra, Jean M. Connors, Gary H. Lyman, Rachel P. Rosovsky
81 [GO] 2021―Jul―14 Physician Experiences in Management of COVID-19-Associated Coagulopathy in Pregnancy: Communication from the ISTH SSC Subcommittee on Women's Health Issues in Thrombosis and Haemostasis Stefan D. Jevtic, A. Kinga Malinowski, Maha Othman, Rezan A Abdul Kadir
82 [GO] 2021―Jul―09 Pathogenic lipid-binding antiphospholipid antibodies are associated with severity of COVID-19 Anne Hollerbach, Nadine Müller-Calleja, Denise Pedrosa, Antje Canisius, Martin F. Sprinzl, Tanja Falter, Heidi Rossmann, Marc Bodenstein, Christian Werner, Ingo Sagoschen, Thomas Münzel, Oliver Schreiner, Visvakanth Sivanathan, Michael Reuter, Johannes Niermann, Peter R. Galle, Luc Teyton, Wolfram Ruf, Karl J. Lackner
83 [GO] 2021―Jul―09 Remote history of VTE is associated with severe COVID-19 in middle and older age: UK Biobank cohort study Jana J Anderson, Frederick K Ho, Claire L Niedzwiedz, S. Vittal Katikireddi, Carlos Celis-Morales, Stamatina Iliodromiti, Paul Welsh, Pierpaolo Pellicori, Evangelia Demou, Claire E Hastie, Donald M Lyall, Stuart R Gray, John F Forbes, Jason MR Gill, Daniel F Mackay, Colin Berry, John GF Cleland, Naveed Sattar, Jill P Pell
84 [GO] 2021―Jul―08 Tissue Factor upregulation is associated with SARS-CoV-2 in the lungs of COVID-19 patients Sandeep Subrahmanian, Alain Borczuk, Steven Salvatore, Kar-Ming Fung, Joan T. Merrill, Jeffrey Laurence, Jasimuddin Ahamed
85 [GO] 2021―Jul―08 Standard prophylactic versus intermediate dose enoxaparin in adults with severe COVID-19: a multi-center, open-label, randomized controlled trial Usha S. Perepu, Isaac Chambers, Abdul Wahab, Patrick Ten Eyck, Chaorong Wu, Sanjana Dayal, Grerk Sutamtewagul, Steven R. Bailey, Lori J. Rosenstein, Steven R. Lentz
86 [GO] 2021―Jul―05 Imbalanced of von Willebrand factor and ADAMTS13 axis is rather a biomarker of strong inflammation and endothelial damage than a cause of thrombotic process in critically-ill COVID-19 patients Bérangère S. Joly, Michael Darmon, Charlotte Dekimpe, Thibault Dupont, Guillaume Dumas, Elise Yvin, Nicolas Beranger, Karen Vanhoorelbeke, Elie Azoulay, Agnès Veyradier
87 [GO] 2021―Jun―24 Suggested treatment of serious complications to Covid-19 vaccination with IdeS, a bacterial antibody-cleaving enzyme Fredrik Kahn, Oonagh Shannon, Lars Björck
88 [GO] 2021―Jun―02 ADAMTS13 regulation of VWF multimer distribution in severe COVID-19 Soracha E. Ward, Helen Fogarty, Ellie Karampini, Michelle Lavin, Sonja Schneppenheim, Rita Dittmer, Hannah Morrin, Siobhan Glavey, Cliona Ni Cheallaigh, Colm Bergin, Ignacio Martin-Loeches, Patrick W. Mallon, Gerard F. Curley, Ross I. Baker, Ulrich Budde, Jamie M. O’Sullivan, James S. O’ Donnell, Niamh O’Connell, Kevin Ryan, Mary Byrne, Liam Townsend, Natalie L McEvoy, Jennifer Clarke, Maria Boylan, Razi Alalqam, Amy P Worrall, Claire Kelly, Eoghan de Barra, Roger Preston Dermot Kenny
89 [GO] 2021―Mai―21 Bleeding risk in hospitalized patients with COVID-19 receiving intermediate- or therapeutic doses of thromboprophylaxis Pablo Demelo-Rodriguez, Ana Isabel Farfán-Sedano, José María Pedrajas, Pilar Llamas, Patricia Sigüenza, María Jesús Jaras, Manuel Quintana-Diaz, Carmen Fernández-Capitán, Behnood Bikdeli, David Jiménez, Manuel Monreal
90 [GO] 2021―Mai―11 Evaluation of laboratory assays for anti-Platelet Factor 4 antibodies after ChAdOx1 nCOV-19 vaccination Sean Platton, Andrew Bartlett, Peter MacCallum, Mike Makris, Vickie McDonald, Deepak Singh, Marie Scully, Sue Pavord
91 [GO] 2021―Apr―28 An observational study to identify the prevalence of thrombocytopenia and anti-PF4/polyanion antibodies in Norwegian health care workers after COVID-19 vaccination Ingvild Hausberg Sørvoll, Kjersti Daae Horvei, Siw Leiknes Ernstsen, Ingvild Jenssen Lægreid, Svetlana Lund, Renathe Henriksen Grønli, Magnus Kringstad Olsen, Hege Karine Jacobsen, Anna Eriksson, Anne Marie Halstensen, Eirik Tjønnfjord, Waleed Ghanima, Maria Therese Ahlen
92 [GO] 2021―Apr―27 Post adenoviral-based COVID-19 vaccines thrombosis: A proposed mechanism Kamran Kadkhoda
93 [GO] 2021―Apr―22 Recommendations for the clinical and laboratory diagnosis of vaccine-induced immune thrombotic thrombocytopenia (VITT) for SARS-CoV-2 infections: Communication from the ISTH SSC Subcommittee on Platelet Immunology. Ishac Nazy, Ulrich J Sachs, Donald M. Arnold, Steven E McKenzie, Phil Choi, Karina Althaus, Maria Therese Ahlen, Ruchika Sharma, Rachael F Grace, Tamam Bakchoul
94 [GO] 2021―Apr―21 Thrombocytopenia with acute ischemic stroke and bleeding in a patient newly vaccinated with an adenoviral vector-based COVID-19 vaccine Rolf Ankerlund Blauenfeldt, Søren Risom Kristensen, Siw Leiknes Ernstsen, Claudia Christina Hilt Kristensen, Claus Ziegler Simonsen, Anne-Mette Hvas
95 [GO] 2021―Apr―21 Antibody-mediated platelet activation in COVID-19: A coincidence or a new mechanism of the dysregulated coagulation system? Karina Althaus, Jan Zlamal, Tamam Bakchoul
96 [GO] 2021―Apr―08 Placental growth factor level in plasma predicts COVID-19 severity and in-hospital mortality David M. Smadja, Aurélien Philippe, Olivier Bory, Nicolas Gendron, Agathe Beauvais, Maxime Gruest, Nicolas Peron, Lina Khider, Coralie L. Guerin, Guillaume Goudot, Françoise Levavasseur, Jérome Duchemin, Frédéric Pene, Cherifa Cheurfa, Tali-Anne Szwebel, Elise Sourdeau, Benjamin Planquette, Caroline Hauw-Berlemont, Bertrand Hermann, Pascale Gaussem, Charles-Marc Samama, Tristan Mirault, Benjamin Terrier, Olivier Sanchez, Bastien Rance, Michaela Fontenay, Jean-Luc Diehl, Richard Chocron
97 [GO] 2021―Apr―07 Biomarkers of coagulation, endothelial function and fibrinolysis in critically-ill patients with COVID-19: A single-centre prospective longitudinal study Ganeem K. Juneja, Matthew Castelo, Calvin H. Yeh, Samantha E. Cerroni, Bettina E. Hansen, James E. Chessum, Joel Abraham, Erblin Cani, Dhruva J. Dwivedi, Douglas D. Fraser, Marat Slessarev, Claudio Martin, Scott McGilvray, Peter L. Gross, Patricia C. Liaw, Jeffrey I. Weitz, Paul Y. Kim
98 [GO] 2021―Mrz―30 A Case Report of Acquired Haemophilia following COVID-19 Vaccine Mansoor Radwi, Sara Farsi
99 [GO] 2021―Mrz―28 Bleeding Risk by Intensity of Anticoagulation in Critically Ill Patients with COVID-19: A Retrospective Cohort Study Rim Halaby, Adam Cuker, Jennifer Yui, Andrew Matthews, Ella Ishaaya, Elizabeth Traxler, Christopher Domenico, Tara Cooper, Ann Tierney, Pardis Niami, Nathalie van der Rijst, Srinath Adusumalli, Jacob Gutsche, Jay Giri, Steven Pugliese, Todd E.H. Hecht, Allyson M. Pishko
100 [GO] 2021―Mrz―16 Similarities and Perspectives on the two C’s - Cancer and COVID-19 Jecko Thachil, Alok Khorana, Marc Carrier
101 [GO] 2021―Feb―27 Platelet-Activating Immune Complexes Identified in Critically Ill COVID-19 Patients Suspected of Heparin-Induced Thrombocytopenia Ishac Nazy, Stefan D Jevtic, Jane C Moore, Angela Huynh, James W Smith, John G Kelton, Donald M Arnold
102 [GO] 2021―Feb―18 Prolonged elevation of D-dimer Levels in Convalescent COVID-19 patients is Independent of the Acute Phase Response Liam Townsend, Helen Fogarty, Adam Dyer, Ignacio Martin-Loeches, Ciaran Bannan, Parthiban Nadarajan, Colm Bergin, Cliona O’ Farrelly, Niall Conlon, Nollaig M. Bourke, Soracha E. Ward, Mary Byrne, Kevin Ryan, Niamh O’ Connell, Jamie M. O’ Sullivan, Cliona Ni Cheallaigh, James S. O’ Donnell
103 [GO] 2021―Feb―07 COVID-19 patients often show high-titer non-platelet-activating anti-PF4/heparin IgG antibodies Justine Brodard, Johanna A. Kremer Hovinga, Pierre Fontana, Jan-Dirk Studt, Yves Gruel, Andreas Greinacher
104 [GO] 2021―Feb―06 Clinical characteristics and risk factors for symptomatic venous thromboembolism in hospitalized COVID-19 patients: A multicenter retrospective study Jun-Ying Li, Hong-Fei Wang, Ping Yin, Di Li, Di-Le Wang, Peng Peng, Wei-Hua Wang, Lan Wang, Xiao-Wei Yuan, Jin-Yuan Xie, Fan Zhou, Nian Xiong, Feng Shao, Chun-Xiu Wang, Xiang Tong, Hao Ye, Wen-Jun Wan, Ben-De Liu, Wen-Zhu Li, Qian Li, Liang V. Tang, Yu Hu, Gregory YH Lip
105 [GO] 2020―Dez―31 Thrombotic thrombocytopenic Purpura as the initial Presentation of COVID-19 Marie-Claude Beaulieu, Danny Sebastien Mettelus, Benjamin Rioux-Massé, Michèle Mahone
106 [GO] 2020―Dez―31 Thrombotic thrombocytopenic purpura (TTP) response following COVID-19 infection: implications for the ADAMTS13-von Willebrand factor axis Satish Maharaj, Ruobing Xue, Adam Rojan
107 [GO] 2020―Dez―11 SARS-CoV-2 Associated Coagulopathy And Thromboembolism Prophylaxis In Children: A Single Centre Observational Study Giovanni Del Borrello, Isaac Giraudo, Claudia Bondone, Marco Denina, Silvia Garazzino, Claudia Linari, Federica Mignone, Giulia Pruccoli, Carlo Scolfaro, Manuela Spadea, Berardino Pollio, Paola Saracco
108 [GO] 2020―Nov―24 The ADAMTS13-von Willebrand factor axis in COVID-19 patients Ilaria Mancini, Luciano Baronciani, Andrea Artoni, Paola Colpani, Marina Biganzoli, Giovanna Cozzi, Cristina Novembrino, Massimo Boscolo Anzoletti, Valentina De Zan, Maria Teresa Pagliari, Roberta Gualtierotti, Stefano Aliberti, Mauro Panigada, Giacomo Grasselli, Francesco Blasi, Flora Peyvandi
109 [GO] 2020―Nov―24 Thromboinflammation in COVID-19: Can α 2 -Macroglobulin Help to Control the Fire? Rainer Seitz, Lutz Gürtler, Wolfgang Schramm
110 [GO] 2020―Nov―21 Vascular neutrophilic inflammation and immunothrombosis distinguish severe COVID-19 from influenza pneumonia Leo Nicolai, Alexander Leunig, Sophia Brambs, Rainer Kaiser, Markus Joppich, Marie Hoffknecht, Christoph Gold, Anouk Engel, Vivien Polewka, Maximilian Muenchhoff, Johannes C. Hellmuth, Adrian Ruhle, Stephan Ledderose, Tobias Weinberger, Heiko Schulz, Clemens Scherer, Martina Rudelius, Michael Zoller, Oliver T. Keppler, Bernhard Zwißler, Michael von Bergwelt-Baildon, Stefan Kääb, Ralf Zimmer, Roman D. Bülow, Saskia von Stillfried, Peter Boor, Steffen Massberg, Kami Pekayvaz, Konstantin Stark
111 [GO] 2020―Okt―29 Is there a role for the ACE2 receptor in SARS-CoV-2 interactions with platelets? Robert A. Campbell, Eric Boilard, Matthew T. Rondina
112 [GO] 2020―Okt―09 COMMENT ON AN ARTICLE: „Coagulopathy in COVID-19 Omer Ć. Ibrahimagić, Dževdet Smajlović, Zikrija Dostović, Suljo Kunić, Aida Šehanović, Biljana Kojić
113 [GO] 2020―Sep―18 COVID-19 patients exhibit reduced procoagulant platelet responses Frederik Denorme, Bhanu Kanth Manne, Irina Portier, Aaron C. Petrey, Elizabeth A. Middleton, Benjamin T. Kile, Matthew T. Rondina, Robert A. Campbell
114 [GO] 2020―Sep―18 Defibrotide in the COVID-19 coagulopathy: What is the timing? Antonio Macciò, Clelia Madeddu, Giovanni Caocci, Sara Oppi, Giorgio La Nasa
115 [GO] 2020―Sep―05 Anticoagulant interventions in hospitalized patients with COVID-19: A scoping review of randomized controlled trials and call for international collaboration Tobias Tritschler, Marie-Eve Mathieu, Leslie Skeith, Marc Rodger, Saskia Middeldorp, Timothy Brighton, Per Morten Sandset, Susan R. Kahn, Derek C. Angus, Marc Blondon, Marc J. Bonten, Marco Cattaneo, Mary Cushman, Lennie P.G. Derde, Maria T. DeSancho, Jean-Luc Diehl, Ewan Goligher, Bernd Jilma, Peter Jüni, Patrick R. Lawler, Marco Marietta, John C. Marshall, Colin McArthur, Carlos Henrique Miranda, Tristan Mirault, Nuccia Morici, Usha Perepu, Christian Schörgenhofer, Michelle Sholzberg, Alex C. Spyropoulos, Steve A. Webb, Ryan Zarychanski, Stéphane Zuily, Grégoire Le Gal
116 [GO] 2020―Sep―02 Letter in response to: Coagulation markers are independent predictors of increased oxygen requirements and thrombosis in COVID-19 Pervinder bhogal, Melanie Jensen, George Collins, Oliver Spooner, Levansri Makalanda, Daniel Hart, Ounali Jaffer
117 [GO] 2020―Sep―02 COVID-19 Coagulopathy in Pregnancy: Critical Review, Preliminary Recommendations and ISTH Registry - Communication from the ISTH SSC for Women’s Health Rezan Abdul Kadir, Takao Kobayashi, Toshiaki Iba, Offer Erez, Jecko Thachil, Sajida Kazi, Ann Kinga Malinowski, Maha Othman
118 [GO] 2020―Aug―31 2020 - Year of COVID-19 David Lillicrap, James H. Morrissey
119 [GO] 2020―Aug―29 Response to “Studies on hemostasis in COVID-19 deserve careful reporting of the laboratory methods, their significance and their limitation”: don’t throw the baby out with the bathwater C. Nougier, R. Benoit, Y. Dargaud
120 [GO] 2020―Aug―29 Incidence of Deep Vein Thrombosis among non-ICU Patients Hospitalized for COVID-19 Despite Pharmacological Thromboprophylaxis: Angelo Porfidia, Angelo Santoliquido, Giulia Cammá, Enrica Porceddu, Roberto Pola
121 [GO] 2020―Aug―29 Response to Maccio et al., “Multifactorial Pathogenesis of COVID-19-related Coagulopathy: Can defibrotide have a role in the early phases of coagulation disorders?” Edward Richardson, Carmelo Carlo-Stella, Ruben Jara, Israel Vlodavsky, Massimo Iacobelli, Jawed Fareed, Clifton Mo, Peter O'Gorman, Gregory Yanik, Marta Palomo, Maribel Diaz-Ricart, Jose M. Moraleda
122 [GO] 2020―Aug―29 Consensus-Based Clinical Recommendations and Research Priorities for Anticoagulant Thromboprophylaxis in Children Hospitalized for COVID-19-Related Illness Neil A. Goldenberg, Anthony Sochet, Manuela Albisetti, Tina Biss, Mariana Bonduel, Julie Jaffray, Graeme MacLaren, Paul Monagle, Sarah O’Brien, Leslie Raffini, Shoshana Revel-Vilk, Nongnuch Sirachainan, Suzan Williams, Ayesha Zia, Christoph Male
123 [GO] 2020―Aug―28 Coagulation biomarkers are independent predictors of increased oxygen requirements in COVID-19 Antoine Rauch, Julien Labreuche, Fanny Lassalle, Julien Goutay, Morgan Caplan, Leslie Charbonnier, Aurelien Rohn, Emmanuelle Jeanpierre, Annabelle Dupont, Alain Duhamel, Karine Faure, Marc Lambert, Eric Kipnis, Delphine Garrigue, Peter J. Lenting, Julien Poissy, Sophie Susen
124 [GO] 2020―Aug―13 Studies on hemostasis in COVID-19 deserve careful reporting of the laboratory methods, their significance and their limitations Michael Hardy, Jonathan Douxfils, Marion Bareille, Sarah Lessire, Isabelle Gouin-Thibault, Pierre Fontana, Thomas Lecompte, François Mullier
125 [GO] 2020―Aug―07 Circulating endothelial progenitors are increased in Covid-19 patients and correlate with SARS-CoV-2 RNA in severe cases Patrizia Mancuso, Antonio Gidaro, Giuliana Gregato, Alessandro Raveane, Paola Cremonesi, Jessica Quarna, Sonia Caccia, Luca Gusso, Stefano Rusconi, Andrea Giacomelli, Chiara Cogliati, Francesco Bertolini
126 [GO] 2020―Aug―07 In vitro hypercoagulability and ongoing in vivo activation of coagulation and fibrinolysis in COVID-19 patients on anticoagulation Annabel Blasi, Fien A. Meijenfeldt, Jelle Adelmeijer, Andrea Calvo, Cristina Ibañez, Juan Perdomo, Juan Carlos Reverter, Ton Lisman
127 [GO] 2020―Aug―07 Is the COVID-19 thrombotic catastrophe complement-connected? Edward M. Conway, Edward L.G. Pryzdial
128 [GO] 2020―Jul―29 Hypoxia - an overlooked trigger for thrombosis in COVID-19 and other critically ill patients Jecko Thachil
129 [GO] 2020―Jul―29 Chronic Therapeutic Anticoagulation is Associated with Decreased Thrombotic Complications in SARS-CoV-2 Infection Daniel J. Lachant, Neil A. Lachant, Peter Kouides, Stephen Rappaport, Paritosh Prasad, R. James White
130 [GO] 2020―Jul―21 Incidence of thrombosis and hemorrhage in hospitalized cancer patients with COVID-19 Rushad Patell, Thomas Bogue, Poorva Bindal, Anita Koshy, Mwanasha Merrill, William C Aird, Kenneth A Bauer, Jeffrey I Zwicker
131 [GO] 2020―Jul―21 Multifactorial pathogenesis of COVID-19-related coagulopathy. Can defibrotide have a role in the early phases of coagulation disorders? Antonio Macciò, Clelia Madeddu, Giovanni Caocci, Giorgio La Nasa
132 [GO] 2020―Jul―21 Fibrinolysis and COVID-19: a tale of two sites? Charithani B. Keragala, Robert L. Medcalf, Paul S. Myles
133 [GO] 2020―Jul―21 The hazard of (sub)therapeutic doses of anticoagulants in non-critically ill patients with Covid-19: the Padua province experience Raffaele Pesavento, Davide Ceccato, Giampaolo Pasquetto, Jacopo Monticelli, Lucia Leone, Annachiara Frigo, Davide Gorgi, Anna Postal, Giuseppe Maria Marchese, Alberto Cipriani, Alois Saller, Cristiano Sarais, Pietro Criveller, Marco Gemelli, Federico Capone, Paola Fioretto, Claudio Pagano, Marco Rossato, Angelo Avogaro, Paolo Simioni, Paolo Prandoni, Roberto Vettor
134 [GO] 2020―Jul―15 Hypofibrinolytic state and high thrombin generation may play a major role in sars-cov2 associated thrombosis Christophe Nougier, Remi Benoit, Marie Simon, Helene Desmurs-Clavel, Guillaume Marcotte, Laurent Argaud, Jean Stephane David, Aurelie Bonnet, Claude Negrier, Yesim Dargaud
135 [GO] 2020―Jul―14 COVID-19-associated coagulopathy - Hypothesis: Are Children protected due to enhanced thrombin inhibition by higher α 2 -Macroglobulin (α2-M)? Wolfgang Schramm, Rainer Seitz, Lutz Gürtler
136 [GO] 2020―Jul―13 ISTH DIC Subcommittee Communication on Anticoagulation in COVID-19 Jecko Thachil, Nicole P. Juffermans, Marco Ranucci, Jean M. Connors, Theodore E. Warkentin, Thomas L. Ortel, Marcel Levi, Toshiaki Iba, Jerrold H. Levy
137 [GO] 2020―Jul―13 Are chilblains a skin expression of COVID-19 microangiopathy? Marie Baeck, Anne Herman, Caroline Peeters, Liliane Marot, Cedric Hermans
138 [GO] 2020―Jul―07 Incidence of Deep Vein Thrombosis among non-ICU Patients Hospitalized for COVID-19 Despite Pharmacological Thromboprophylaxis Angelo Santoliquido, Angelo Porfidia, Antonio Nesci, Giuseppe De Matteis, Giuseppe Marrone, Enrica Porceddu, Giulia Cammà, Igor Giarretta, Massimo Fantoni, Francesco Landi, Antonio Gasbarrini, Roberto Pola, Valeria Abbate, Nicola Acampora, Giovanni Addolorato, Fabiana Agostini, Maria E. Ainora, Elena Amato, Gloria Andriollo, Brigida E. Annicchiarico, Mariangela Antonelli, Gabriele Antonucci, Armuzzi Alessandro, Christian Barillaro, Fabiana Barone, Rocco D.A. Bellantone, Andrea Bellieni, Andrea Benicchi, Francesca Benvenuto, Filippo Berloco, Roberto Bernabei, Antonio Bianchi, Luigi M. Biasucci, Stefano Bibbò, Federico Biscetti, Nicola Bonadia, Alberto Borghetti, Giulia Bosco, Silvia Bosello, Vincenzo Bove, Giulia Bramato, Vincenzo Brandi, Dario Bruno, Maria C. Bungaro, Alessandro Buonomo, Livia Burzo, Angelo Calabrese, Andrea Cambieri, Giulia Cammà, Marcello Candelli, Gennaro Capalbo, Lorenzo Capaldi, Esmeralda Capristo, Luigi Carbone, Silvia Cardone, Angelo Carfì, Annamaria Carnicelli, Cristiano Caruso, Francesco A. Casciaro, Lucio Catalano, Roberto Cauda, Andrea L. Cecchini, Lucia Cerrito, Michele Ciaburri, Rossella Cianci, Sara Cicchinelli, Arturo Ciccullo, Francesca Ciciarello, Antonella Cingolani, Maria C. Cipriani, Gaetano Coppola, Andrea Corsello, Federico Costante, Marcello Covino, Stefano D'Addio, Alessia D'Alessandro, Maria E. D'alfonso, Emanuela D'Angelo, Francesca D'Aversa, Fernando Damiano, Tommaso De Cunzo, Giuseppe De Matteis, Martina De Siena, Francesco De Vito, Valeria Del Gatto, Paola Del Giacomo, Fabio Del Zompo, Davide Della Polla, Luca Di Gialleonardo, Simona Di Giambenedetto, Roberta Di Luca, Luca Di Maurizio, Alex Dusina, Alessandra Esperide, Domenico Faliero, Cinzia Falsiroli, Massimo Fantoni, Annalaura Fedele, Daniela Feliciani, Andrea Flex, Evelina Forte, Francesco Franceschi, Laura Franza, Barbara Funaro, Mariella Fuorlo, Domenico Fusco, Maurizio Gabrielli, Eleonora Gaetani, Antonella Gallo, Giovanni Gambassi, Matteo Garcovich, Antonio Gasbarrini, Irene Gasparrini, Silvia Gelli, Antonella Giampietro, Laura Gigante, Gabriele Giuliano, Giorgia Giuliano, Bianca Giupponi, Elisa Gremese, Caterina Guidone, Amerigo Iaconelli, Angela Iaquinta, Michele Impagnatiello, Riccardo Inchingolo, Raffaele Iorio, Immacolata M. Izzi, Cristina Kadhim, Daniele I. La Milia, Francesco Landi, Giovanni Landi, Rosario Landi, Massimo Leo, Antonio Liguori, Rosa Liperoti, Marco M. Lizzio, Maria R. Lo Monaco, Pietro Locantore, Francesco Lombardi, Loris Lopetuso, Valentina Loria, Angela R. Losito, Andrea Lupascu, Noemi Macerola, Giuseppe Maiuro, Francesco Mancarella, Francesca Mangiola, Alberto Manno, Debora Marchesini, Giuseppe Marrone, Ilaria Martis, Anna M. Martone, Emanuele Marzetti, Maria V. Matteo, Luca Miele, Alessio Migneco, Irene Mignini, Alessandro Milani, Domenico Milardi, Massimo Montalto, Flavia Monti, Davide Moschese, Barbara P.L. Mothaenje, Celeste A. Murace, Rita Murri, Marco Napoli, Elisabetta Nardella, Gerlando Natalello, Simone M. Navarra, Antonio Nesci, Alberto Nicoletti, Tommaso Nicoletti, Rebecca Nicolò, Nicola Nicolotti, Enrico C. Nista, Eugenia Nuzzo, Veronica Ojetti, Francesco C. Pagano, Cristina Pais, Alfredo Papa, Luigi G. Papparella, Mattia Paratore, Giovanni Pecorini, Simone Perniola, Erika Pero, Giuseppe Perrinello, Luca Petricca, Martina Petrucci, Chiara Picarelli, Andrea Piccioni, Giulia Pignataro, Raffaele Pignataro, Marco Pizzoferrato, Fabrizio Pizzolante, Roberto Pola, Caterina Policola, Maurizio Pompili, Valerio Pontecorvi, Francesca Ponziani, Valentina Popolla, Enrica Porceddu, Angelo Porfidia, Giuseppe Privitera, Gabriele Pulcini, Simona Racco, Francesca Raffaelli, Gian L. Rapaccini, Luca Richeldi, Emanuele Rinninella, Sara Rocchi, Stefano Romano, Federico Rosa, Laura Rossi, Raimondo Rossi, Enrica Rossini, Elisabetta Rota, Fabiana Rovedi, Gabriele Rumi, Andrea Russo, Luca Sabia, Andrea Salerno, Sara Salini, Lucia Salvatore, Dehara Samori, Maurizio Sanguinetti, Luca Santarelli, Paolo Santini, Angelo Santoliquido, Francesco Santopaolo, Michele C. Santoro, Francesco Sardeo, Caterina Sarnari, Luisa Saviano, Tommaso Schepis, Francesca Schiavello, Giancarlo Scoppettuolo, Luisa Sestito, Carlo Settanni, Valentina Siciliano, Benedetta Simeoni, Andrea Smargiassi, Domenico Staiti, Leonardo Stella, Eleonora Taddei, Rossella Talerico, Enrica Tamburrini, Claudia Tarli, Pietro Tilli, Enrico Torelli, Matteo Tosato, Alberto Tosoni, Luca Tricoli, Marcello Tritto, Mario Tumbarello, Anita M. Tummolo, Federico Valletta, Giulio Ventura, Lucrezia Verardi, Lorenzo Vetrone, Giuseppe Vetrugno, Elena Visconti, Raffaella Zaccaria, Lorenzo Zelano, Lorenzo Zileri Dal Verme, Giuseppe Zuccalà
139 [GO] 2020―Jul―03 Specific coagulation markers may provide more therapeutic targets in COVID-19 patients receiving prophylactic anticoagulant Ning Tang, Huan Bai, Dongsheng Xiong, Ziyong Sun
140 [GO] 2020―Jul―03 Antiphospholipid antibodies in patients with COVID-19: a relevant observation? Katrien M.J. Devreese, Eleni A. Linskens, Dominique Benoit, Harlinde Peperstraete
141 [GO] 2020―Jul―03 Living through a pandemic - A time for clarity, courage and truth Claire McLintock
142 [GO] 2020―Jul―01 Response to ‘the association between D-dimer in COVID-19 patients and mortality remains beset of uncertainties’ Litao Zhang, Xinsheng Yan, Yiyao Gong, Zhenlu Zhang
143 [GO] 2020―Jul―01 COVID-19: a collision of complement, coagulation and inflammatory pathways Anoop J. Chauhan, Laura J. Wiffen, Thomas P. Brown
144 [GO] 2020―Jul―01 Lupus anticoagulant is frequent in patients with Covid-19: Response to Reply Inès Harzallah, Agathe Debliquis, Bernard Drénou
145 [GO] 2020―Jun―19 Coagulopathy in COVID-19 Toshiaki Iba, Jerrold H. Levy, Marcel Levi, Jecko Thachil
146 [GO] 2020―Jun―19 Curative anticoagulation prevents endothelial lesion in COVID-19 patients Lina Khider, Nicolas Gendron, Guillaume Goudot, Richard Chocron, Caroline Hauw-Berlemont, Charles Cheng, Nadia Rivet, Helene Pere, Ariel Roffe, Sébastien Clerc, David Lebeaux, Benjamin Debuc, David Veyer, Bastien Rance, Pascale Gaussem, Sébastien Bertil, Cécile Badoual, Philippe Juvin, Benjamin Planquette, Emmanuel Messas, Olivier Sanchez, Jean-Sébastien Hulot, Jean-Luc Diehl, Tristan Mirault, David M. Smadja
147 [GO] 2020―Jun―16 Fibrinolysis and COVID-19: a plasmin paradox Robert L. Medcalf, Charithani B. Keragala, Paul S. Myles
148 [GO] 2020―Jun―11 Thromboprophylaxis in a patient with COVID-19 and severe hemophilia A on emicizumab prophylaxis María Isabel Rivas-Pollmar, María Teresa Álvarez-Román, Nora V. Butta-Coll, Mónica Martín Salces, Sara García-Barcenilla, Victor Jiménez-Yuste
149 [GO] 2020―Jun―11 Response to ‘all these D-dimers in COVID-19 Litao Zhang
150 [GO] 2020―Jun―11 The need for accurate D-dimer reporting in COVID-19: Communication from the ISTH SSC on Fibrinolysis Jecko Thachil, Colin Longstaff, Emmanuel J. Favaloro, Giuseppe Lippi, Tetsumei Urano, Paul Y. Kim
151 [GO] 2020―Jun―04 The association between D-dimers in COVID-19 patients and mortality remains beset of uncertainties Jean-Christophe Gris, Paul Loubet, Claire Roger, Eva Cochery-Nouvellon, Jean-Marc Mauboussin, Laurent Muller, Sylvie Bouvier, Didier Laureillard, Saber Davide Barbar, Érick Mercier, Jean-Yves Lefrant, Albert Sotto
152 [GO] 2020―Jun―03 Forum article: The protective rather than prothrombotic fibrinogen in COVID-19 and other inflammatory states Jecko Thachil
153 [GO] 2020―Mai―29 All those D-dimers in COVID-19 Jecko Thachil
154 [GO] 2020―Mai―29 Frequency of lupus anticoagulant in Covid-19 patients Inès Harzallah, Agathe Debliquis, Bernard Drénou
155 [GO] 2020―Mai―29 Reply to ‘Ibuprofen and thromboembolism in SARS-COV2’ Songping Cui, Shuo Chen, Lihui Ke
156 [GO] 2020―Mai―28 Macrothrombosis and stroke in patients with mild Covid-19 infection Michael G. Fara, Laura K. Stein, Maryna Skliut, Susan Morgello, Johanna T. Fifi, Mandip S. Dhamoon
157 [GO] 2020―Mai―27 Scientific and Standardization Committee Communication: Clinical Guidance on the Diagnosis, Prevention and Treatment of Venous Thromboembolism in Hospitalized Patients with COVID-19 Alex C. Spyropoulos, Jerrold H. Levy, Walter Ageno, Jean Marie Connors, Beverley J Hunt, Toshiaki Iba, Marcel Levi, Charles Marc Samama, Jecko Thachil, Dimitrios Giannis, James D. Douketis
158 [GO] 2020―Mai―19 Heparin - an old drug with multiple potential targets in Covid-19 therapy Ulf Lindahl, Jin-Ping Li
159 [GO] 2020―Mai―16 Ibuprofen and thromboembolism in SARS-COV2 Arian Arjomandi Rad, Robert Vardanyan, Natalie R Tas
160 [GO] 2020―Mai―14 Anticoagulant and antiarrhythmic effects of heparin in the treatment of COVID-19 patients Francisco Sandro Menezes-Rodrigues, José Gustavo Padrão Tavares, Marcelo Pires de Oliveira, Rafael Guzella de Carvalho, Paolo Ruggero Errante, Murched Omar Taha, Djalma José Fagundes, Afonso Caricati-Neto
161 [GO] 2020―Mai―14 Response to “uncertainties on the prognostic value of D-dimers in COVID-19 patients” Litao Zhang
162 [GO] 2020―Mai―07 Coagulopathy of COVID-19 and antiphospholipid antibodies Nathan T. Connell, Elisabeth M. Battinelli, Jean M. Connors
163 [GO] 2020―Mai―07 Response to 'What do monitoring platelet counts in COVID-19 teach us?' Xiaobo Yang, You Shang
164 [GO] 2020―Mai―07 Response to “Lupus anticoagulant is frequent in patients with Covid-19 Ning Tang
165 [GO] 2020―Mai―05 Incidence of venous thromboembolism in hospitalized patients with COVID-19 Saskia Middeldorp, Michiel Coppens, Thijs F. van Haaps, Merijn Foppen, Alexander P. Vlaar, Marcella C.A. Müller, Catherine C.S. Bouman, Ludo F.M. Beenen, Ruud S. Kootte, Jarom Heijmans, Loek P. Smits, Peter I. Bonta, Nick van Es
166 [GO] 2020―Apr―29 Hereditary Haemorrhagic Telangiectasia: a disease not to be forgotten during the COVID-19 pandemic Eleonora Gaetani, Giulio Cesare Passali, Maria Elena Riccioni, Annalisa Tortora, Roberto Pola, Guido Costamagna, Antonio Gasbarrini
167 [GO] 2020―Apr―28 Uncertainties on the prognostic value of D-dimers in COVID-19 patients Jean-Christophe Gris, Isabelle Quéré, Antonia Pérez-Martin, Jean-Yves Lefrant, Albert Sotto
168 [GO] 2020―Apr―28 What do monitoring platelet counts in COVID-19 teach us? Jecko Thachil
169 [GO] 2020―Apr―28 DIC in COVID-19: Implications for Prognosis and Treatment? Rainer Seitz, Wolfgang Schramm
170 [GO] 2020―Apr―24 Type and dose of heparin in COVID-19 Jecko Thachil, Ning Tang, Satoshi Gando, Anna Falanga, Marcel Levi, Cary Clark, Toshiaki Iba, Marco Cattaneo
171 [GO] 2020―Apr―24 Fibrinolytic abnormalities in acute respiratory distress syndrome (ARDS) and versatility of thrombolytic drugs to treat COVID-19 Claire S Whyte, Gael B Morrow, Joanne L Mitchell, Pratima Chowdary, Nicola J Mutch
172 [GO] 2020―Apr―24 Direct oral anticoagulant plasma levels striking increase in severe COVID-19 respiratory syndrome patients treated with antiviral agents. The Cremona experience Sophie Testa, Paolo Prandoni, Oriana Paoletti, Rossella Morandini, Maurizio Tala, Claudia Dellanoce, Matteo Giorgi-Pierfranceschi, Monia Betti, Gian Battista Danzi, Angelo Pan, Gualtiero Palareti
173 [GO] 2020―Apr―23 Laboratory haemostasis monitoring in COVID-19 Jecko Thachil, Ning Tang, Satoshi Gando, Anna Falanga, Marcel Levi, Cary Clark, Toshiaki Iba
174 [GO] 2020―Apr―23 Lupus anticoagulant is frequent in patients with Covid-19 Inès Harzallah, Agathe Debliquis, Bernard Drénou
175 [GO] 2020―Apr―22 High incidence of venous thromboembolic events in anticoagulated severe COVID-19 patients Jean-François Llitjos, Maxime Leclerc, Camille Chochois, Jean-Michel Monsallier, Michel Ramakers, Malika Auvray, Karim Merouani
176 [GO] 2020―Apr―19 D-dimer levels on admission to predict in-hospital mortality in patients with Covid-19 Litao Zhang, Xinsheng Yan, Qingkun Fan, Haiyan Liu, Xintian Liu, Zejin Liu, Zhenlu Zhang
177 [GO] 2020―Apr―17 Thromboinflammation and the hypercoagulability of COVID-19 Jean M. Connors, Jerrold H. Levy
178 [GO] 2020―Apr―17 RE: ISTH interim guidance to recognition and management of coagulopathy in COVID-19 Satoshi Akima, Claire McLintock, Beverley J Hunt
179 [GO] 2020―Apr―17 Potential of Heparin and Nafamostat Combination Therapy for COVID-19 Hidesaku Asakura, Haruhiko Ogawa
180 [GO] 2020―Apr―17 Thrombocytopenia and Its Association with Mortality in Patients with COVID-19 Xiaobo Yang, Qingyu Yang, Yaxin Wang, Yongran Wu, Jiqian Xu, Yuan Yu, You Shang
181 [GO] 2020―Apr―17 The procoagulant pattern of patients with COVID-19 acute respiratory distress syndrome Marco Ranucci, Andrea Ballotta, Umberto Di Dedda, Ekaterina Bayshnikova, Marco Dei Poli, Marco Resta, Mara Falco, Gianni Albano, Lorenzo Menicanti
182 [GO] 2020―Apr―17 Hypercoagulability of COVID-19 patients in Intensive Care Unit. A Report of Thromboelastography Findings and other Parameters of Hemostasis Mauro Panigada, Nicola Bottino, Paola Tagliabue, Giacomo Grasselli, Cristina Novembrino, Veena Chantarangkul, Antonio Pesenti, Fora Peyvandi, Armando Tripodi
183 [GO] 2020―Apr―17 ISTH interim guidance on recognition and management of coagulopathy in COVID-19: A Comment Christopher D. Barrett, Hunter B. Moore, Michael B. Yaffe, Ernest E. Moore
184 [GO] 2020―Apr―17 Response to 'Reply to Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy' Ning Tang
185 [GO] 2020―Apr―17 Reply to "Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy" Rubén Coto-Hernández, María Teresa Fábregas Ruano
186 [GO] 2020―Apr―16 COVID-19: 2020 a year in turmoil David Lillicrap, James H. Morrissey
187 [GO] 2020―Apr―15 Pathological evidence of pulmonary thrombotic phenomena in severe COVID-19 Marisa Dolhnikoff, Amaro Nunes Duarte-Neto, Renata Aparecida de Almeida Monteiro, Luiz Fernando Ferraz da Silva, Ellen Pierre de Oliveira, Paulo Hilário Nascimento Saldiva, Thais Mauad, Elnara Marcia Negri
188 [GO] 2020―Apr―15 Impact of the COVID-19 pandemic on therapeutic choices in Thrombosis-Hemostasis C. Hermans, C. Lambert
189 [GO] 2020―Apr―15 Venous thromboembolism in COVID-19 patients Angelo Porfidia, Roberto Pola
190 [GO] 2020―Apr―15 Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia Deepa RJ Arachchillage, Mike Laffan
191 [GO] 2020―Apr―15 Pulmonary thrombosis in 2019-nCoV pneumonia? Francesco Marongiu, Elvira Grandone, Doris Barcellona
192 [GO] 2020―Apr―13 DOACs and ‘newer’ haemophilia therapies in COVID-19 Jecko Thachil, Ning Tang, Satoshi Gando, Anna Falanga, Marco Cattaneo, Marcel Levi, Cary Clark, Toshiaki Iba
193 [GO] 2020―Apr―11 Exploring possible mechanisms for COVID-19 induced thrombocytopenia: Unanswered Questions Ariunzaya Amgalan, Maha Othman
194 [GO] 2020―Apr―09 Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia Songping Cui, Shuo Chen, Xiunan Li, Shi Liu, Feng Wang
195 [GO] 2020―Apr―08 Tissue Plasminogen Activator (tPA) Treatment for COVID-19 Associated Acute Respiratory Distress Syndrome (ARDS): A Case Series Janice Wang, Negin Hajizadeh, Ernest E. Moore, Robert C. McIntyre, Peter K Moore, Livia A. Veress, Michael B. Yaffe, Hunter B. Moore, Christopher D. Barrett
196 [GO] 2020―Apr―02 The versatile heparin in COVID-19 Jecko Thachil
197 [GO] 2020―Mrz―27 Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy Ning Tang, Huan Bai, Xing Chen, Jiale Gong, Dengju Li, Ziyong Sun
198 [GO] 2020―Mrz―26 ISTH interim guidance on recognition and management of coagulopathy in COVID-19 Jecko Thachil, Ning Tang, Satoshi Gando, Anna Falanga, Marco Cattaneo, Marcel Levi, Cary Clark, Toshiaki Iba
199 [GO] 2020―Mrz―25 Disseminated intravascular coagulation in patients with 2019-nCoV pneumonia David Lillicrap
200 [GO] 2020―Feb―19 Abnormal Coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia Ning Tang, Dengju Li, Xiong Wang, Ziyong Sun
 [1] 

200 Ergebisse       Seite 1



[de][en]

Letzte Änderung 2025―Jul―29 14:55:09 UTC

© Daten-Quadrat 2022       Done in 0.007 sec